Population pharmacokinetic modeling of tildrakizumab (MK-3222), an anti–interleukin-23p19 monoclonal antibody, in healthy volunteers and subjects with psoriasis

2018 ◽  
Vol 79 (3) ◽  
pp. AB224 ◽  
2016 ◽  
Vol 33 (7) ◽  
pp. 1657-1670 ◽  
Author(s):  
Maiara Cássia Pigatto ◽  
Bibiana Verlindo de Araujo ◽  
Bruna Gaelzer Silva Torres ◽  
Stephan Schmidt ◽  
Paolo Magni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document